Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125669311 | 12566931 | 1 | I | 20160628 | 20160707 | 20160718 | 20160718 | EXP | GB-MHRA-TPP23157515C2987890YC1467107322792 | PHHY2016GB094176 | SANDOZ | 82.00 | YR | M | Y | 58.00000 | KG | 20160718 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125669311 | 12566931 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 80 MG | U | 77766 | 80 | MG | |||||||
| 125669311 | 12566931 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 1 DF, QD AT NIGHT. | 1 | DF | U | 0 | 1 | DF | QD | ||||
| 125669311 | 12566931 | 3 | C | DERMOL | BENZALKONIUM CHLORIDECHLORHEXIDINE HYDROCHLORIDEISOPROPYL MYRISTATEPARAFFIN | 1 | Unknown | 1 DF, BID ON AFFECTED AREAS | 52 | DF | U | 0 | 1 | DF | BID | ||||
| 125669311 | 12566931 | 4 | C | DORZOLAMIDE HYDROCHLORIDE. | DORZOLAMIDE HYDROCHLORIDE | 1 | Unknown | 1 GGT BID | 1149.91699 | Gtt | U | 0 | 1 | GTT | BID | ||||
| 125669311 | 12566931 | 5 | C | FUSIDIC ACID | FUSIDIC ACID | 1 | Unknown | APPLY SMALL VOLUME TO AFFECTED SITES TWICE A DAY | 0 | ||||||||||
| 125669311 | 12566931 | 6 | C | NASEPTIN | CHLORHEXIDINE HYDROCHLORIDENEOMYCIN SULFATE | 1 | Unknown | 2 DF, QID APPLY INSIDE BOTH NOSTRILS | 8 | DF | U | 0 | 2 | DF | QID | ||||
| 125669311 | 12566931 | 7 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | 1 DF, QD | 414 | DF | U | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125669311 | 12566931 | 1 | Product used for unknown indication |
| 125669311 | 12566931 | 2 | Blood cholesterol increased |
| 125669311 | 12566931 | 3 | Product used for unknown indication |
| 125669311 | 12566931 | 4 | Product used for unknown indication |
| 125669311 | 12566931 | 5 | Product used for unknown indication |
| 125669311 | 12566931 | 6 | Product used for unknown indication |
| 125669311 | 12566931 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125669311 | 12566931 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125669311 | 12566931 | Abnormal dreams | |
| 125669311 | 12566931 | Myalgia | |
| 125669311 | 12566931 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125669311 | 12566931 | 1 | 20141201 | 0 | ||
| 125669311 | 12566931 | 2 | 20160628 | 0 | ||
| 125669311 | 12566931 | 3 | 20160602 | 0 | ||
| 125669311 | 12566931 | 4 | 20141201 | 0 | ||
| 125669311 | 12566931 | 5 | 20160505 | 20160506 | 0 | |
| 125669311 | 12566931 | 6 | 20160628 | 0 | ||
| 125669311 | 12566931 | 7 | 20150511 | 0 |